Ciclosporin in Autoimmune Diseases -

Ciclosporin in Autoimmune Diseases

1st International Symposium, Basle, March 18–20, 1985

Rosemarie Schindler (Herausgeber)

Buch | Softcover
XII, 386 Seiten
2011 | 1. Softcover reprint of the original 1st ed. 1985
Springer Berlin (Verlag)
978-3-642-70609-7 (ISBN)
106,99 inkl. MwSt

Preface to CyA Proceedings.- 1. Autoimmunity and Ciclosporin (CyA).- Prevailing Theories in Autoimmune Disorders.- Genetic Role in Autoimmunity.- The Mechanism of Action of Ciclosporin: A Continuing Puzzle.- Contrasting Effects of Ciclosporin on Humoral and Cell-mediated Immunity in Patients with Autoimmune Diseases.- Pharmacokinetics and Interactions of Ciclosporin.- Side Effects and Safety of Sandimmun® in Long-term Treatment of Transplant Patients.- Ciclosporin-associated Nephropathy.- Ciclosporin in Autoimmune Diseases - Side Effects (with Emphasis on Renal Dysfunction) and Recommendations for Use.- Clinical Effects and Renal Side Effects in Patients with Autoimmune Diseases Treated with Ciclosporin (CyA).- 2. Multiple Sclerosis - Myasthenia Gravis - Polymyositis.- The Use of Ciclosporin (CyA) in Multiple Sclerosis - Trial Design and Tolerance.- The Effect of Ciclosporin versus Azathioprine on the Course of Multiple Sclerosis; Design of a Long-term Follow-up Study and Side Effects.- Ciclosporin in the Treatment of Myasthenia Gravis: Preliminary Results from a Pilot Study.- Ciclosporin in Myasthenia Gravis.- Ciclosporin in the Treatment of Polymyositis/Idiopathic Cardiomyopathy.- 3. Diabetes Mellitus Type I.- Type I Diabetes Mellitus: Rationale for Immune Intervention.- Effects of Ciclosporin on Insulin Secretion in Recent Onset Type I Diabetes Mellitus.- Ciclosporin in Insulin-dependent Diabetes Mellitus: Design of Controlled Studies.- 4. Uveitis and Behçet's Disease.- Effectiveness of Ciclosporin on Sight-threatening Endogenous Uveitis.- Treatment of Noninfectious Inflammatory Disorders of the Eye with Ciclosporin.- Ciclosporin (CyA) in the Treatment of Retinal Vasculitis.- Ciclosporin Treatment of Autoimmune Inflammatory Disorders of the Eye.- Treatment of Ocular Involvement in Behçet's Disease with Ciclosporin A (Preliminary Report).- Preliminary Results of a Randomized Prospective Study on Treatment of Posterior Uveitis with Ciclosporin or Prednisolone.- Ciclosporin in Idiopathic Posterior Uveitis; Interim Report of a Randomized Double-masked Study.- Ciclosporin (CyA) Versus Conventional Therapy in Behçet's Disease. Preliminary Observations of a Masked Study.- A Double-masked Study of Ciclosporin Treatment in Behçet's Disease.- 5. Primary Biliary Cirrhosis - Crohn's Disease.- Primary Biliary Cirrhosis.- Effect of Ciclosporin (CyA) on Suppressor Cell Function in Patients with Primary Biliary Cirrhosis.- Treatment of Primary Biliary Cirrhosis with Ciclosporin (CyA), Pilot Study.- Ciclosporin Therapy in Primary Biliary Cirrhosis (PBC): A Pilot Study in 10 Patients.- Ciclosporin (CyA) in Primary Biliary Cirrhosis (PBC). A Multicentre, Double-blind, Placebo-controlled Long-term Therapeutic Study. The Study Design.- Ciclosporin for Crohn's Disease.- Controlled Study of Ciclosporin versus Corticosteroids in Acute Crohn's Disease: Methodology and Early Findings.- 6. Sarcoidosis - Dermatology.- Ciclosporin (CyA) in the Treatment of Pulmonary Sarcoidosis.- Ciclosporin (CyA) as an Alternative to Steroids in the Treatment of Sarcoidosis and Cryptogenic Interstitial Lung Diseases.- Ciclosporin in the Treatment of Progressive Systemic Sclerosis.- Ciclosporin Inhibits the Effector Function of the T Effector Cell of Delayed Type Hypersensitivity.- Treatment of Pemphigus with Ciclosporin.- Treatment of Bullous Dermatoses with Ciclosporin (CyA).- Ciclosporin (CyA) in Pemphigus and Bullous Pemphigoid.- 7. Endocrine Ophthalmopathy.- Endocrine Ophthalmopathy.- Ciclosporin in the Treatment of Graves' Ophthalmopathy.- Treatment of Graves' Ophthalmopathy with Ciclosporin.- A Pilot Study of Ciclosporin in Endocrine Ophthalmopathy.- Ciclosporin Treatment in Severe Graves' Ophthalmopathy.- 8. Hematology.- Ciclosporin (CyA) as Primary Treatment for Severe Acute Aplastic Anaemia.- Ciclosporin for Therapy of Severe Aplastic Anemia (SAA) and Pure Red Cell Aplasia (PRCA).- Experience with Ciclosporin (CyA) in the Management of Pure Red-Cell Apla

Erscheint lt. Verlag 6.12.2011
Zusatzinfo XII, 386 p.
Verlagsort Berlin
Sprache englisch
Maße 170 x 244 mm
Gewicht 693 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Dermatologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Pharmazie PTA / PKA
Schlagworte autoimmune disease • Diseases • Research
ISBN-10 3-642-70609-6 / 3642706096
ISBN-13 978-3-642-70609-7 / 9783642706097
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Differentialdiagnostik und Therapie bei Kindern und Jugendlichen

von Peter Höger

Buch (2022)
Thieme (Verlag)
165,00